Biogen's new Alzheimer's drug serves as a rallying cry for drug pricing reforms
A coalition of employers and health care purchasers are calling on the top House and Senate leaders to take a hard look at the “astronomical …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
